Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy
Purpose To evaluate off-label use of netarsudil 0.02% for treatment of corneal edema associated with Fuchs dystrophy. Design Prospective, randomized clinical trial. Methods Twenty-nine subjects with symptomatic Fuchs dystrophy were…